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"is special issue focuses on the current approaches for
diagnosis, evaluation, and management of autoimmune
diseases of the anterior segment of the eye, which range from
immune keratoconjunctivitis to anterior uveitis. Immune
diseases of the anterior segment of the eye may be caused by
several local or systemic conditions and may present in
a wide range of diseases including dry eye syndrome, ocular
cicatricial pemphigoid (OCP), graft versus host disease
(GVHD), and some forms of anterior uveitis often associ-
ated with systemic autoimmune diseases such as ankylosing
spondylitis. "ese conditions represent some of the most
difficult conditions to diagnose and manage in ophthal-
mology and often require a multidisciplinary approach.
Specifically, in this special issue, Tao and colleagues
evaluated reliability and validity of the most commonly used
quality of life questionnaires in Chinese patients with dry eye
disease; Szepessy et al. evaluated the alterations of central
retinal and choroidal thickness and the severity of anterior
chamber inflammation in patients with acute anterior uveitis
associated with seronegative spondyloarthropathy; Qui et al.
described the characteristics of ocular manifestations of
a large cohort of patients with a diagnosis of acute or chronic
ocular GVHD; Nebbioso et al. evaluated the potential role of
vascular endothelial growth factor (VEGF) and mucins in
patients with vernal keratoconjunctivitis (VKC). In addition,
Leuci et al. reported the long-term clinical outcome of 6
patients with OCP treated with intravenous immunoglob-
ulin therapy (IVIg), which maintained remission of the
disease and did not show progression, for a total follow-up
period of 9 years after the end of IVIg treatment.
"e topics presented in this special issue evaluated few
aspects of the large and heterogeneous group of disorders
which may be included in the group of autoimmune diseases
of the anterior segment of the eye. However, it is clear that
these conditions require a multidisciplinary approach and
often represent a challenge for clinicians due to the lack of
specific diagnostic criteria and specific treatments. In fact,
most immune diseases are currently treated with local or
systemic corticosteroids or immunosuppressive drugs,
which may be effective in controlling the inflammatory
reaction but are commonly associated with important local
and systemic side effects. By this point of view, the increasing
understanding of novel pathogenic mechanisms of auto-
immune diseases will lead to the development of novel, more
specific drugs designed to target the molecules involved in
the inflammatory reaction.
In addition, autoimmune diseases of the anterior seg-
ment of the eye may have complications that extend beyond
the anterior segment and can impair visual function. In fact,
visual functionmay be directly impaired in dry eye disease or
immune keratoconjuctivits due to corneal damage and
scarring, or, alternatively, other autoimmune diseases such
as anterior uveitis may induce glaucoma with damage to the
optic nerve or macular changes, which cause decrease of
visual acuity. Not only the diseases but also some of their
treatments may induce long-term adverse effects impairing
visual function; for example, chronic use of corticosteroid
eye drops in patients with immune diseases of the eye is
a well-known cause of cataract and glaucoma.
Based on these considerations, it is clear that a further
progress in understanding the pathogenesis of ocular im-
mune reactions is highly sought after, together with more
standardized diagnostic procedures and protocols for several
autoimmune diseases of the anterior segment of the eye.
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Such progresses will hopefully also lead to the development
of novel and more targeted therapeutic approaches that can
improve clinical outcome and quality of life of patients with
these diseases.
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